References
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–238.
- Avonts M, Cloetens HLeyns C, et al. Domus medica richtlijnen: aanvraag van laboratoriumtests door huisartsen: hoofdstuk schildklierlijden. Huisarts Nu. 2011;40(6):23-25.
- Pirahanchi YPhysiology Jialal I., thyroid, stimulating hormone (TSH). StatPearls (Internet). Treasure Island (FL). Stat Pearls Publishing; 2018 Jan [cited 2018 Jul]
- Schneider C, Feller M, Bauer DC, et al. Initial evaluation of thyroid dysfunction - are simultaneous TSH and fT4 tests necessary? Plos One. 2018;13(4).
- Visser WE, van Mullem AA, Visser TJ, et al. Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. Clin Endocrinol (Oxford). 2013;79(5):595–605.
- Gurnell M, Halsall DJ, Chatterjee VK. What should be done when thyroid function tests do not make sense? Clin Endocrinol (Oxford). 2011;74(6):673–678.
- Koulouri O, Moran C, Halsall D, et al. Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab. 2013;27(6):745–762.
- Dayan C. Interpretation of thyroid function tests. Lancet. 2001;357:619–624.
- Stockigt JR, Lim CF. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract Res Clin Endocrinol Metab. 2009;23(6):753–767.
- Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab. 2013;27(5):647–661.
- Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem. 1994;40(11):1996–2005.
- Favresse J, Burlacu MC, Maiter D, et al. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev. 2018;39(5):830–850.
- Censi S, Cavedon E, Fernando SW, et al. Calcitonin measurement and immunoassay interference: a case report and literature review. Clin Chem Lab Med. 2016;54(12):1861–1870.
- Erregragui K, Cheillan F, Defoort JP, et al. Autoantibodies to thyroid hormone: the role of thyroglobulin. Clin Exp Immunol. 1996;105:140–147.
- Zouwail SA, O’Toole AM, Clark PM, et al. Influence of thyroid hormone autoantibodies on 7 thyroid hormone assays. Clin Chem. 2008;54(5):927–928.
- Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(4):894–904.
- Beck-Peccoz T, Lania A, Beckers A, et al. European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J. 2013;2:76–82.
- Ortiga-Carvalho TM, Aniket RS, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014;10(10):582–591.
- AM, Refetoff S. Impaired sensitivity to thyroid hormone: defects of transport, metabolism and action. Endotext, NCBI bookshelf South Darthmouth (MA) [ cited 2015 Aug 20].
- Dumitrescu AM, Refetoff S. The syndromes of reduced sensitivity to thyroid hormone. Biochim Biophys Acta. 2013;1830(7):3987–4003.
- Rulander NJ, Cardamone D, Senior M, et al. Interference from anti-streptavidine-antibody. Arch Pathol Lab Med. 2013;137(8):1141–1146.